Oxford BioDynamics PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by P eter Presland, was filed 10 Apr 2025.
Oxford BioDynamics PLC: what insiders have been doing
Every trade that managers of Oxford BioDynamics PLC disclose to RNS (LSE) is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Oxford BioDynamics PLC in twelve months, the latest record being from 10 April 2025.
Looking back to 2019, when coverage begins, insiders filed 11 purchases and 3 sales.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -57.8%Entry £0.00 · Close at T+365 £0.00
- -48.9%Entry £0.11 · Close at T+365 £0.06
- -43.2%Entry £1.63 · Close at T+365 £0.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Oxford BioDynamics PLC Strong Buy (bullish), based on 1 analysts. Average price target: £0.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended September 2025 · cache
- 3,398,553 shares@ £0.0044100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD5H8572RNS:5613233Canonical exit: 9 Jul 2025 (T+90)
- 0London Stock Exchange (XLON)ISIN GB00BD5H8572RNS:5449634
- 125,000 shares@ £0.33943.3% of flowLondon Stock Exchange (XLON)ISIN GB00BD5H8572RNS:4967771
- 0London Stock Exchange (XLON) (sale and re-purchase) Outside a trading venue (spousal transfer)ISIN GB00BD5H8572RNS:4958786Canonical exit: 31 Jan 2024 (T+90)
- 777,000 shares@ £0.00383.1% of flowLondon Stock Exchange (XLON)ISIN GB00BD5H8572RNS:4943437
- 115,000 shares@ £0.45253.6% of flowLondon Stock Exchange (XLON)ISIN GB00BD5H8572RNS:4925741
- 443,673 shares@ £0.14739.9% of flowXLONISIN GB00BD5H8572RNS:4886895Canonical exit: 26 Apr 2023 (T+90)
- 162,051 shares@ £0.0018London Stock Exchange (XLON)ISIN GB00BD5H8572FCA-NSM:4578479Canonical exit: 9 Feb 2023 (T+90)
- 65,000 shares@ £0.0014100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD5H8572FCA-NSM:4426266Canonical exit: 28 Sept 2022 (T+90)
- 25,000 shares@ £0.0017London Stock Exchange (XLON)ISIN GB00BD5H8572FCA-NSM:4378523Canonical exit: 18 Aug 2022 (T+90)
- 30,000 shares@ £0.002London Stock Exchange (XLON)ISIN GB00BD5H8572FCA-NSM:4352480Canonical exit: 26 Jul 2022 (T+90)
- 10,000 sharesOutside a trading venueISIN GB00BD5H8572FCA-NSM:LSE20190709070010_14140954_20200326185124940_29222-0Canonical exit: 6 Oct 2019 (T+90)
- 14,000 sharesOutside a trading venueISIN GB00BD5H8572FCA-NSM:LSE20190709070010_14140954_20200326185124940_29222-1Canonical exit: 6 Oct 2019 (T+90)
- 7,814 sharesOutside a trading venueISIN GB00BD5H8572FCA-NSM:LSE20190709070010_14140954_20200326185124940_29222-2Canonical exit: 3 Oct 2019 (T+90)
- 22,000 shares@ £0.0168100.0% of flowOutside a trading venueISIN GB00BD5H8572FCA-NSM:LSE20190215100152_13971004_20200326185109847_14026Canonical exit: 15 May 2019 (T+90)
15 of 15 declarations
About Oxford BioDynamics PLC
Oxford BioDynamics PLC is a biotechnology company focused on developing diagnostic tests based on epigenetic biomarkers. It concentrates on applications in healthcare, particularly for cancer and autoimmune diseases.
